BioSpace News Archive

Pictured: U.S. Chamber of Commerce/Courtesy of Ado

Policy

DOJ, Chamber of Commerce Tussle in Court Over IRA’s Drug Price Negotiations

The legal battle over the Inflation Reduction Act’s price negotiation program moved to federal court in Ohio with the Department of Justice and U.S. Chamber of Commerce sparring about the law.

September 18, 2023

·

2 min read

·

Tristan Manalac

Pictured: Bristol Myers Squibb office in California

Business

Samsung Biologics Strikes $242M Manufacturing Deal with BMS for Cancer Antibody

The deal is an expansion of an existing production agreement between the companies and just one of several deals with large pharma companies that the Korean biotech has scooped up this year.

September 18, 2023

·

2 min read

·

Connor Lynch

Pictured: GSK's office in Poznan, Poland/iStock, W

FDA

FDA Approves GSK’s Momelotinib for Myelofibrosis Patients with Anemia

Following a regulatory victory for Jemperli in endometrial cancer last month, GSK continued its oncology winning streak with an FDA approval for momelotinib in adult myelofibrosis patients with anemia.

September 18, 2023

·

2 min read

·

Tristan Manalac

Pictured: Illustration of a blood clot in a blood

Drug Development

Anthos Stops Mid-Stage Atrial Fibrillation Trial Due to ‘Unprecedented’ Efficacy

After evidence of “overwhelming reduction” in bleeding compared to Bayer and J&J’s Xarelto, Anthos Therapeutics has ended its Phase II atrial fibrillation study for abelacimab ahead of schedule.

September 18, 2023

·

2 min read

·

Tristan Manalac

Drug Development

AlzeCure Gets an Abstract on Phase II Clinical Data with ACD440 for Neuropathic Pain Accepted at Pain Conference

AlzeCure Pharma announced that an abstract on ACD440, the leading non-opioid drug candidate in the Painless platform, has been accepted for presentation at the annual pain conference to be held by the Swedish Pain Society in Uppsala, Sweden, on October 12-13.

September 18, 2023

·

5 min read

Zylox-Tonbridge was Added to the FTSE Global Equity Index Series

Zylox-Tonbridge is pleased to learn that the Company’s stock was added to the FTSE Global Equity Index Series, including FTSE Global Total-Cap Index and FTSE Global Micro Cap Index, according to the results of the semi-annual review of FTSE GEIS.

September 18, 2023

·

1 min read

Genetown

Broken String Biosciences Closes $15M Series A Funding Round

Broken String Biosciences announced that it has closed a $15 million Series A investment round, co-led by Illumina Ventures and Mérieux Equity Partners, with contributions from HERAN Partners, and existing investors Tencent and Dieter von Holtzbrinck Ventures.

September 18, 2023

·

4 min read

Business

AiViva Biopharma Appoints Lester J. Kaplan, PhD to the Board of Directors

AiViva Biopharma Inc., a clinical-stage biotechnology company developing innovative therapies to address major unmet medical needs, announced the appointment of Dr. Lester J. Kaplan, PhD to its board of directors.

September 18, 2023

·

1 min read

Genetown

Atrial Fibrillation Study with Abelacimab Stopped Early by the Data Monitoring Committee Due to an Overwhelming Reduction in Bleeding as Compared to a DOAC (Direct Oral Anticoagulant)

Anthos Therapeutics, Inc., a clinical stage company developing innovative therapies for cardiovascular diseases, founded by Blackstone Life Sciences, announced that the AZALEA-TIMI 71 Phase 2 study in 1,287 patients with atrial fibrillation at moderate-to-high risk of stroke, met its primary endpoint.

September 18, 2023

·

8 min read

Drug Development

Curi Bio Launches Nautilus™ and Stingray™ Platforms for Advancing Translational Research

Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, announced the commercial launch of its Nautilus™ and Stingray™ platforms for advancing preclinical drug discovery.

September 18, 2023

·

5 min read